Home EnGeneIC

EnGeneIC

In operation
Series B
Developer of New Cancer Treatment Drugs
Basic
Enterprise Profile

Basic Information

EnGeneIC Ltd. is a bioscience company dedicated to the development and commercialization of anticancer and chemotherapy drugs for in vivo use. The company's drug/siRNA delivery vehicles offer a range of options for optimizing the delivery of clinically significant doses of drugs and siRNA to target cancer cells within the body. It serves customers in Australia, Singapore, Japan, and India. The company was founded in 2000 and is headquartered in Lane Cove West, Australia.
EnGeneIC Limited
Sydney,NewSouthWales,Australia
15~50 people
January 01, 2000
info@engeneic.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Cell Technology
Concept
Disease Treatment Tumor
Application Scenarios
Innovative Drugs Small Nucleic Acid Drugs